[{"data":1,"prerenderedAt":140},["ShallowReactive",2],{"drug-potassium-phosphate":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":22,"regimens":36,"contraindications":55,"warnings":65,"renal":73,"monitoring":74,"interactions":75,"review":76,"examples":79,"atc":80,"iran":82,"usApproval":89,"links":95,"populations":106},"potassium-phosphate",1,{"fa":7,"en":8},"پتاسیم فسفات (تزریقی)","Potassium phosphates (injection)","blood",{"fa":11,"en":12},"مکمل الکترولیت","Electrolyte replenisher",[14],{"name":15,"market":16},"Potassium Phosphates","US",[18,19,20,21],"potassium phosphate","پتاسیم فسفات","فسفات تزریقی","KPhos",[23],{"id":24,"form":25,"route":26,"label":27,"concentration":28,"markets":31,"refs":32},"vial-3","injection","iv","Phosphorus 3 mmol\u002FmL (potassium 4.4 mEq\u002FmL), 5\u002F15 mL vials",{"amount":5,"unit":29,"perUnit":30},"application","vial",[16],[33],{"source":34,"section":35},"fda-potassium-phosphates","3",[37],{"id":38,"disease":39,"label":40,"population":43,"type":44,"unit":45,"dose":46,"refs":50},"hypo","hypophosphatemia",{"fa":41,"en":42},"اصلاح هیپوفسفاتمی در مایعات وریدی — فقط اگر پتاسیم سرم زیر ۴ mEq\u002FL","Correction of hypophosphataemia in IV fluids — only if serum potassium is below 4 mEq\u002FL",{},"notCalculated","mg",{"reason":47},{"fa":48,"en":49},"دوز فردی بر اساس فسفر سرم، وزن و منابع دیگر؛ هر mL حاوی ۳ mmol فسفر و ۴٫۴ mEq پتاسیم. فقط پس از رقیق‌سازی در حجم بیشتر؛ سرعت و غلظت حداکثر طبق بخش ۲. فسفر، پتاسیم، کلسیم و منیزیم پایش شود.","Dose individualised by serum phosphorus, weight and other sources; each mL has 3 mmol phosphorus and 4.4 mEq potassium. Only after dilution in a larger volume; maximum rate and concentration per section 2. Monitor phosphorus, potassium, calcium and magnesium.",[51,53],{"source":34,"section":52},"2.1",{"source":34,"section":54},"2.2",[56],{"id":57,"severity":58,"text":59,"refs":62},"ci","block",{"fa":60,"en":61},"هیپرکالمی؛ هیپرفسفاتمی؛ نارسایی شدید کلیه (eGFR زیر ۳۰) یا ESRD؛ هیپرکلسمی یا هیپوکلسمی قابل‌توجه.","Hyperkalaemia; hyperphosphataemia; severe renal impairment (eGFR \u003C30) or ESRD; hypercalcaemia or significant hypocalcaemia.",[63],{"source":34,"section":64},"4",[66],{"text":67,"refs":70},{"fa":68,"en":69},"عوارض قلبی جدی با تزریق رقیق‌نشده یا سریع؛ آمبولی ریه از رسوب (کلسیم-فسفات)؛ هیپرکالمی؛ هیپوکلسمی؛ آسیب ورید.","Serious cardiac reactions with undiluted or rapid infusion; pulmonary embolism from precipitates (calcium phosphate); hyperkalaemia; hypocalcaemia; vein damage.",[71],{"source":34,"section":72},"5",[],[],[],{"status":77,"reviewer":78,"date":78},"unverified",null,[],[81],"B05XA06",{"status":83,"refs":84},"not-found",[85],{"source":86,"section":87,"url":88},"darooyab-generic","search","https:\u002F\u002Fwww.darooyab.ir\u002FSearch?q=Potassium%20phosphates",{"kind":90,"refs":91,"id":94},"ANDA",[92],{"source":34,"section":93},"SPL approval \u002F marketing category","ANDA216274",[96,99,103],{"kind":97,"url":98,"label":94},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=216274",{"kind":100,"url":101,"label":102},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=41a85cca-c463-4f39-9335-177b04c290a9","FDA Potassium phosphates",{"kind":104,"url":105,"label":81},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=B05XA06",{"pregnancy":107,"lactation":116,"pediatric":124,"geriatric":132},{"level":108,"text":109,"quote":112,"refs":113},"caution",{"fa":110,"en":111},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary Administration of the recommended dose of Potassium Phosphates Injection is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes.",[114],{"source":34,"section":115},"8.1",{"level":108,"text":117,"quote":120,"refs":121},{"fa":118,"en":119},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Risk Summary Phosphorus and potassium are present in human milk.",[122],{"source":34,"section":123},"8.2",{"level":108,"text":125,"quote":128,"refs":129},{"fa":126,"en":127},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and effectiveness of Potassium Phosphates Injection have been established in pediatric patients as a source of phosphorus: in intravenous fluids to correct hypophosphatemia when oral or enteral replacement is not possible, insufficient, or contraindicated. for parenteral nutrition when oral or enteral nutrition …",[130],{"source":34,"section":131},"8.4",{"level":108,"text":133,"quote":136,"refs":137},{"fa":134,"en":135},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","In general, dose selection of Potassium Phosphates Injection for an elderly patient should be cautious, starting at the low end of the dosing range because of the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.",[138],{"source":34,"section":139},"8.5",1792444418341]